Risk of false negative JC virus PCR in CSF of natalizumab-associated PML patients reflects low PML lesion volume.

M. T. Wijburg, I. Kleerekooper, B. I. Witte, M. de Vos, C. Warnke, B. M. J. Uitdehaag, F. Barkhof, J. Killestein, M. P. Wattjes

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)54-55
JournalMultiple Sclerosis
Volume22
Publication statusPublished - Sep 2016

Cite this